Crossmark

Analysis of ICIs alone or in combination rechallenged outcomes after progression from first-line ICIs plus chemotherapy in patients with advanced non-small cell lung cancer

Crossref DOI link: https://doi.org/10.1038/s41598-024-83947-7

Published Online: 2025-01-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yin, Guisen

Liu, Xin

Yu, Xiangtao

Tan, Song

Liu, Fen
Funding

Funding for this research was provided by:

Binzhou Medical College Traditional Chinese Medicine Discipline Integration Science and Technology Program (2024ZYYKJ09)

Shandong Provincial natural fund project (ZR2022LZY013)

Shandong Provincial Traditional Chinese Medicine Science and Technology Project (M-2022039)

Hunan Provincial Health Commission Project (D202313017815)
License Information

Text and Data Mining valid from 2025-01-02

Version of Record valid from 2025-01-02
More Information

Article History

Received: 13 August 2024

Accepted: 18 December 2024

First Online: 2 January 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below